Drug intelligence / Profile preview

ED-FOL

Development stage
Unknown
Lead developer
Zaiva Lifesciences
Modality
Small Molecules
Administration
Oral
01

Overview

ED-FOL is a marketed multi-ingredient nutraceutical product developed and manufactured by Zaiva Lifesciences, an Indian pharmaceutical company. It is formulated as an oral tablet containing a combination of L-arginine (500 mg), proanthocyanidin (75 mg), selenium (65 mcg), ginkgo biloba (40 mg), ginseng (42.5 mg), green tea extract (10 mg), garlic powder (2 mg), and lycopene (2500 mcg). This product is designed to support cardiovascular health, provide antioxidant protection, and potentially aid male reproductive health. L-arginine serves as a precursor for nitric oxide, which promotes vasodilation and improved blood flow, while the botanical extracts and selenium offer synergistic antioxidant effects to combat oxidative stress.

Brand names
ED-FOL
02

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on ED-FOL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ED-FOL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call